CSPG4-X-CD3

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCSPG4-X-CD3
Drug Alias NameTBCC-3CSPG4-X-CD3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT cell surface glycoprotein CD3 inhibitorsT lymphocytes modulatorsChondroitin sulfate proteoglycan 4 modulators
TargetsT cell surface glycoprotein CD3Chondroitin sulfate proteoglycan 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotecnol Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotecnol Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A